We are live on ! Find out more
SG Americas Securities

SG Americas Securities Portfolio holdings

AUM $92.9B
1-Year Est. Return 36.98%
This Fund
S&P 500
This Quarter Est. Return
+12.35%
1 Year Est. Return
+36.98%
3 Year Est. Return
+96.33%
5 Year Est. Return
+110.18%
10 Year Est. Return
+436.29%
AUM
$10.7B
AUM Growth
+$1.97B
Cap. Flow
+$3.37B
Cap. Flow %
31.43%
Top 10 Hldgs %
17.21%
Holding
3,563
New
485
Increased
1,264
Reduced
1,053
Closed
493

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$217M
2
CSCO icon
Cisco
CSCO
+$184M
3
GLD icon
SPDR Gold Trust
GLD
+$90.5M
4
BMY icon
Bristol-Myers Squibb
BMY
+$87.5M
5
AMGN icon
Amgen
AMGN
+$87.3M

Sector Composition

Rank Sector Weight
1 Technology 15.31%
2 Healthcare 9.78%
3 Consumer Discretionary 9.7%
4 Industrials 7.55%
5 Financials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
2851
Heron Therapeutics
HRTX
$96.8M
$45K ﹤0.01%
26,464
-4,096
-13% -$4.51K
NSTG
2852
DELISTED
NanoString Technologies, Inc.
NSTG
$45K ﹤0.01%
60,207
+48,968
+436% +$51.7K
CTEV
2853
Claritev Corp
CTEV
$450M
$44K ﹤0.01%
772
+375
+94% +$22.8K
EVA
2854
DELISTED
Enviva Inc.
EVA
$44K ﹤0.01%
+44,076
New +$122K
CARM
2855
DELISTED
Carisma Therapeutics
CARM
$43K ﹤0.01%
14,671
+1,018
+7% +$3.03K
IPSC icon
2856
Century Therapeutics
IPSC
$363M
$43K ﹤0.01%
12,818
+2,478
+24% +$4.51K
MNST icon
2857
CALL
Monster Beverage
MNST
$92.1B
$43K ﹤0.01%
50,800
PG icon
2858
PUT
Procter & Gamble
PG
$345B
$43K ﹤0.01%
56,700
CUTR
2859
DELISTED
Cutera, Inc.
CUTR
$43K ﹤0.01%
+12,314
New +$37.5K
KZR
2860
DELISTED
Kezar Life Sciences
KZR
$42K ﹤0.01%
4,395
+1,111
+34% +$9.77K
KR icon
2861
CALL
Kroger
KR
$35.4B
$41K ﹤0.01%
109,200
NB
2862
NioCorp Developments
NB
$756M
$41K ﹤0.01%
+12,828
New +$46.4K
VALE icon
2863
CALL
Vale
VALE
$63.1B
$41K ﹤0.01%
+1,351,200
New +$19.4M
DNMR
2864
DELISTED
Danimer Scientific, Inc.
DNMR
$41K ﹤0.01%
+1,011
New +$55K
GSAT icon
2865
Globalstar
GSAT
$10.8B
$40K ﹤0.01%
1,382
-538
-28% -$11.8K
IMA
2866
ImageneBio Inc
IMA
$64.9M
$40K ﹤0.01%
1,685
+791
+88% +$25.8K
OPRT icon
2867
Oportun Financial
OPRT
$276M
$40K ﹤0.01%
+10,198
New +$43.6K
RLYB icon
2868
Rallybio
RLYB
$84.7M
$40K ﹤0.01%
+2,102
New +$51.4K
SST icon
2869
System1
SST
$16.5M
$40K ﹤0.01%
1,795
+188
+12% +$2.78K
XFOR icon
2870
X4 Pharmaceuticals
XFOR
$405M
$40K ﹤0.01%
1,589
+444
+39% +$10.8K
LENZ
2871
LENZ Therapeutics
LENZ
$158M
$40K ﹤0.01%
2,190
+430
+24% +$7.1K
ALDX icon
2872
Aldeyra Therapeutics
ALDX
$93.5M
$39K ﹤0.01%
+11,028
New +$34K
FDX icon
2873
PUT
FedEx
FDX
$74.1B
$39K ﹤0.01%
48,900
RMNI icon
2874
Rimini Street
RMNI
$459M
$39K ﹤0.01%
+12,012
New +$33K
KLTR icon
2875
Kaltura
KLTR
$211M
$38K ﹤0.01%
19,639
+6,957
+55% +$12.3K

Similar funds

SG Americas Securities's Q4 2023 Portfolio in Review

As of Q4 2023, SG Americas Securities held 3,563 positions worth $10.7B, up 23% from $8.75B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

SG Americas Securities deployed $3.37B of net new capital in Q4 2023, opening 485 new positions and adding to 1,264 existing holdings. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 888,731 shares worth $79.2M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $192M trimmed.

  • SG Americas Securities's largest Q4 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 888,731 shares worth $79.2M.
  • SG Americas Securities added most to Amazon in Q4 2023, an estimated $217M increase.
  • SG Americas Securities's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $192M.
  • SG Americas Securities fully exited iShares US Financials ETF in Q4 2023, selling an estimated $63.1M.
  • SG Americas Securities's ten largest holdings make up 17% of its $10.7B portfolio in Q4 2023.
  • SG Americas Securities opened 485 new positions and closed 493 in Q4 2023.
  • SG Americas Securities's portfolio value rose 23% quarter-over-quarter to $10.7B.

Based on SG Americas Securities's 13F filing for Q4 2023, filed 12 Jan 2024.